Is SGP or SLDB more undervalued in 2026?

CirclFi compares SpyGlass Pharma, Inc. (SGP) and Solid Biosciences Inc. (SLDB) using 13 institutional-grade valuation models. SGP has a Quality of Company score of 5.0/10 while SLDB scores 4.4/10.

Which is a better buy — SGP or SLDB?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do SGP and SLDB valuations compare?

SGP at $19.84 and SLDB at $7.07 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

SGP vs SLDB Valuation Comparison 2026 — Intrinsic Value Analysis

SGP

Biotechnology

SpyGlass Pharma, Inc.

Quality

5.0

out of 10

Value Trap

—

Price

$19.84

Last close

Models

7/13

Active

SLDB

Biotechnology

Solid Biosciences Inc.

Quality

4.4

out of 10

Value Trap

SAFE

Price

$7.07

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	SGP Fair Value	SGP Upside	SLDB Fair Value	SLDB Upside
Bayesian DCF	Intrinsic	$5.82	-70.7%	$3.47	-50.9%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$2.00	-89.9%	$4.75	-32.9%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for SGP vs SLDB — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

SGP vs SLDB — Which Stock Is More Undervalued?

SGP scores higher with a 5.0/10 quality rating vs SLDB's 4.4/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing SpyGlass Pharma, Inc. (SGP) and Solid Biosciences Inc. (SLDB) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

SGP currently trades at $19.84 with a QOC of 5.0/10, while SLDB trades at $7.07 with a QOC of 4.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).